Next Article in Journal / Special Issue
20 kDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease
Previous Article in Journal
Mismatch Repair System Genomic Scars in Gastroesophageal Cancers: Biology and Clinical Testing
Previous Article in Special Issue
Intestinal Immune Homeostasis and Inflammatory Bowel Disease: A Perspective on Intracellular Response Mechanisms
Review

Making Decisions about Dietary Therapy in Inflammatory Bowel Disease

1
Institute of Human Nutrition, Columbia University Irving Medical Center, New York, NY 10032, USA
2
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Columbia University Irving Medical Center, New York, NY 10032, USA
*
Author to whom correspondence should be addressed.
Gastrointest. Disord. 2020, 2(4), 353-365; https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord2040032
Received: 4 September 2020 / Revised: 3 October 2020 / Accepted: 4 October 2020 / Published: 7 October 2020
Treatment for inflammatory bowel disease (IBD) deserves an informed shared decision-making process between patient and doctor. IBD spans a spectrum of phenotypes that impact each patient uniquely. While treatment has primarily consisted of medical or surgical therapy, dietary approaches have become increasingly relevant. A majority of patients with IBD use some form of dietary modification, and it is common for patients to do this without their physicians’ knowledge. Lack of medical supervision can lead to nutritional deficiencies and a worsening disease state. Some patients work with their medical team to pursue a well-defined exclusion diet as a primary therapy, such as the specific carbohydrate diet, exclusive enteral nutrition, or the Crohn’s disease exclusion diet. The motivations to use dietary therapy for IBD remain unclear and the effectiveness has not been definitively established for many approaches. It is necessary for medical providers to be knowledgeable and to foster open communication with their patients in order to ensure the highest likelihood of remission. This review provides an overview of dietary treatment options, the current knowledge about patient motivations for pursuing dietary therapy, and the roles of patient empowerment and patient activation. We outline areas of improvement for the decision-making process. View Full-Text
Keywords: Crohn’s disease; dietary therapy; inflammatory bowel disease; nutritional therapy; shared decision-making; ulcerative colitis Crohn’s disease; dietary therapy; inflammatory bowel disease; nutritional therapy; shared decision-making; ulcerative colitis
MDPI and ACS Style

Solomon, S.; Park, E.; Picoraro, J.A. Making Decisions about Dietary Therapy in Inflammatory Bowel Disease. Gastrointest. Disord. 2020, 2, 353-365. https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord2040032

AMA Style

Solomon S, Park E, Picoraro JA. Making Decisions about Dietary Therapy in Inflammatory Bowel Disease. Gastrointestinal Disorders. 2020; 2(4):353-365. https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord2040032

Chicago/Turabian Style

Solomon, Sydney, Eunie Park, and Joseph A. Picoraro 2020. "Making Decisions about Dietary Therapy in Inflammatory Bowel Disease" Gastrointestinal Disorders 2, no. 4: 353-365. https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord2040032

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop